From January 2014 to January 2023, information from 150 patients who underwent robotic thoracic surgery was gathered and examined retrospectively. Patients ineligible for robotic surgery included those with suspected mediastinal lymph node involvement (N2), tumors in the lobar bronchus, or chest wall involvement necessitating rib resection, as well as those needing re-thoracotomy.
Among the 150 patients who underwent robotic thoracic surgery, 106 underwent anatomic pulmonary resection at our institution. The first 20 patients underwent pulmonary resection by RAL, whereas the next 86 consecutive patients underwent pulmonary resection with CPRL-4. These 86 CPRL cases were analyzed and divided into two groups: patients whose specimens were removed traditionally via intercostal utility thoracotomy (group A, n = 32) and consecutive patients whose specimens were removed via subcostal trans-diaphragmatic incision (group B, n = 54). In group A, after pulmonary resection was complete, the anterior port was extended to a 3- or 4-cm intercostal access thoracotomy to remove the specimen from the chest.
Age, sex, body mass index, comorbidity, surgery type, operation time, blood loss, conversion rate, hospitalization duration, and postoperative complication rates were retrospectively reviewed and analyzed descriptively. The duration of each patient's operation was documented as the total docking time, console time, and closure duration. Docking time was specified as the period between the initial incision (inclusive of opening all ports, including the service port) and the moment the surgeon assumed the console position. The console time was defined as the duration between the point at which the surgeon sat at the console and the point at which the resected material was removed and the robotic arms were undocked from the patient, following bleeding and air leak control. The conversion was defined as a rib-spreading thoracotomy after the robot was undocked.
In our clinic, pain scores were routinely recorded since minimally invasive pulmonary resections were initiated. The pain levels of the patients under study were regularly assessed every 6 hours, commencing on the first day after the operation. The Visual Analog Scale (VAS) was employed to gauge patient pain scores, with 0 representing no pain and 10 indicating the most severe pain experienced by the patient. Pain scores for patients were computed over three successive postoperative days. Additionally, SF36 life quality scoring was used to evaluate the patient's quality of life in the first month postoperatively6.
Descriptive statistics, including means, medians, standard deviations, maximums, minimums, frequencies, and percentages, were employed. The distributions of variables were evaluated utilizing Kolmogorov-Smirnov tests. Mann-Whitney U tests were utilized to compare quantitative data, whereas Chi-square tests were used to compare qualitative data.Statistical analyses were performed using SPSS Statistics.
The median age of the patients was 64 years (range: 50-72 years), with 54.6% being male (n = 47). Comorbidities included coronary artery disease, hypertension, obesity, and diabetes in 26 patients (30.2%). Cervical mediastinoscopy was performed in 41 patients (47.7%), and EBUS was performed in 14 patients (16.3%). Surgical resections comprised right upper (25.6%, n = 22), right lower (32.6%, n = 28), left upper (22.1%, n = 19), and left lower (19.8%, n = 17) lobectomies. Seven patients (8.1%) underwent conversion due to arterial bleeding during robotic resection. No postoperative mortality was observed. Pathological staging included stages I (n = 34), II (n = 41), and III (n = 11) in 39.5%, 47.7%, and 12.8% of patients, respectively. Thirty-one patients (36%) experienced complications, including atrial fibrillation (n = 12), postoperative pneumonia (n = 10), and prolonged air leaks (n = 9). The mean duration of hospitalization was 6.36 ± 2.4 days (range: 3-14 days). The mean estimated blood loss was 245.5 ± 60.5. No instances of postoperative hypercarbia or acidosis due to CO2 insufflation were detected.
No statistically significant differences were observed in age, sex, body mass index, comorbidities, complications, hospital stay, intensive care unit (ICU) stay, adequate lymph node staging, tumor side or size, pulmonary resection type, and intraoperative estimated blood loss between groups A and B (Table 1). None of the patients required a postoperative ICU stay longer than 24 h. The mean tumor size was larger in group B than in group A (3.2 ± 1.8 vs. 2.62 ± 1.1) (p > 0.05). The mean docking time was significantly higher in group B than in group A (26.2 ± 5.3 vs. 17.8 ± 4.1) (p = 0.001). Although the mean console time was shorter while operation time was higher in group B than in group A, these differences were not statistically significant (p > 0.05). Regarding early-stage postoperative pain, group B had significantly lower pain scores compared to group A (Table 2) (p < 0.05). The mean clinical follow-up period was 26.4 ± 12.3 months (range: 3-44 months). There was no significant difference between the groups in terms of postoperative first-month life quality evaluation according to SF36 life quality scoring (Table 3).

Figure 1: Localization of robotic ports and subcostal trans-diaphragmatic service port incision. Preoperatively marked port locations on the patient undergoing CPRL. Please click here to view a larger version of this figure.

Figure 2: Illustration of the subcostal trans-diaphragmatic incision. An illustration showing the relation between the subcostal port and the diaphragm. Please click here to view a larger version of this figure.
Table 1: Comparative data on Group A and Group B. m: Mann-Whitney u test, X²: Chi-square test, RUL: right upper lobectomy, RLL: right lower lobectomy, LUL: left upper lobectomy, LLL: left lower lobectomy. Please click here to download this Table.
Table 2: Comparison of early-stage postoperative pain between the groups. VAS: Visual Analog Scale, m: Mann Whitney-U test. Please click here to download this Table.
Table 3: Evaluation of Postoperative 1-month life quality according to SF36 life quality scoring. m: Mann Whitney-U test. Please click here to download this Table.
Supplementary Figure 1: The surgical instruments used in the study. Please click here to download this File.